Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study. - Wikidata - awgldk - TriplyDB

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.

http://www.wikidata.org/entity/Q40148008

about

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards Monitoring of the Immune Dysfunction in Cancer Patients The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients.Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.Standard radiotherapy but not chemotherapy impairs systemic immunity in non-small cell lung cancer.Systematic evaluation of immune regulation and modulation Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.Heterogeneity Among Neutrophils.Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients.The Role of Myeloid-Derived Suppressor Cells in Viral Infection.A clinical and biological perspective of human myeloid-derived suppressor cells in cancer.Developing immunotherapeutic strategies to target brain tumors.Human neutrophils in the saga of cellular heterogeneity: insights and open questions.Neutrophils in cancer.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.GM-CSF signalling blockade and chemotherapeutic agents act in concert to inhibit the function of myeloid-derived suppressor cells in vitro.Myeloid-Derived Suppressor Cells.Development of a Modular Assay for Detailed Immunophenotyping of Peripheral Human Whole Blood Samples by Multicolor Flow Cytometry.Dysfunctional Natural Killer Cells in the Aftermath of Cancer Surgery.Clinical implication of tumor-associated and immunological parameters in melanoma patients treated with ipilimumab.Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study.CIMT 2017: Anniversary symposium - Report on the 15th CIMT Annual Meeting of the Association for Cancer Immunotherapy.Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.Myeloid-derived suppressor cells coming of age.Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.Myeloid Cells and Chronic Liver Disease: a Comprehensive Review.Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types?Mannan-induced Nos2 in macrophages enhances IL-17-driven psoriatic arthritis by innate lymphocytes.

P2860

Q26744395-CD669DA9-84A7-4C60-9442-F04B6B0F9959 Q28072712-E6014CD3-B4F8-4C72-A739-E2DA2862C21E Q28073691-823BE9DE-8CDE-421A-B0C4-A29D8C4798D2 Q33564156-1D76FD63-2797-4CDC-BD62-12166AB605FB Q33816141-E724EE04-B592-467F-B128-668969B6C0DC Q37559245-F26C1392-2CE4-4A7A-966F-5222D4B91ECD Q37713498-60A9AEA4-BCC0-46B8-838F-696BDCD69FBB Q38702891-CC0E32C4-B622-44E9-9B54-372A260182DA Q38755022-BD8B3B4A-D253-4ECB-898A-A571E30A82AB Q38767735-B4B26068-3C47-4BA4-9964-88E530F3C54C Q38774994-CCF9EAE2-4BF9-4A7E-9586-B26D775D62D9 Q38847251-58B05437-4084-4AE9-9D3A-579B8CA6F20E Q38851464-E89018B1-03D1-48A9-B3C7-8DDDB698E7EB Q38936493-3AAE5EB9-99B3-46B5-AD92-4F0508E10518 Q38936555-39AC80B0-5EF8-4186-9C81-A73A90DBE385 Q39313889-F93D3C87-9CA7-4A22-B08B-3A39243D4865 Q40032613-228FE4CD-1C76-41F1-87D4-F77D5670F106 Q40385399-D092F377-A601-40E4-BD64-8E87D284CA62 Q40952760-17BBA255-943C-459D-907A-39545C8AAE5D Q41574368-A551D4FA-1155-4B99-B6A5-81BDD0B7BE2D Q42968783-45831D7A-E2F4-4832-8196-8447F6282020 Q46138352-62F13104-452A-4C04-9842-BDDAD693D97B Q47122613-2884402D-7EA6-40AA-A202-44C9ACE83CFC Q47563950-9ABD31A4-4309-46C8-9F9C-CFDE12788A81 Q48215791-7B156DB5-F18D-4ABD-BF9E-B7627EB993D8 Q48293607-6397FBB7-1CA9-496F-B0F1-DA5725E61162 Q50127735-89687C1C-35DC-4A56-814F-8AA345BD17D1 Q52668399-FF409D33-381D-45DA-A9A0-A439E90C1352 Q55027825-64907305-1A39-469D-A0BC-4C2273F17BB8

P2860

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study.

http://www.wikidata.org/entity/Q40148008

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Toward harmonized phenotyping ...... results from an interim study.

@en

type

label

Toward harmonized phenotyping ...... results from an interim study.

@en

prefLabel

Toward harmonized phenotyping ...... results from an interim study.

@en

P1433

Q40148008-072FF666-5832-4EAB-9964-CC97D2EA701D

P1476

Q40148008-A281D9C5-43F1-413A-A055-21CBF3459F4D

P2093

Q40148008-1BDA5F8E-F165-4A26-96D7-DE742B27C5F3

Q40148008-2718CBA0-604B-4818-B384-615AEE0AD28C

Q40148008-375C6F31-9D44-4045-8319-AC1CFDD46D8E

Q40148008-8F8348AE-16E9-49EB-82E7-FD2734F8B091

Q40148008-ADEFB702-774C-41B5-B4BC-36BF7DA072F2

Q40148008-BFD8B8DD-9EBC-4761-AC6B-FF6727312113

Q40148008-EAE02267-EE2B-4224-996A-57BD6AB1C1BF

P2860

Q40148008-02F06673-3F6B-4A7B-9473-F3D159C72D43

Q40148008-0C736FD1-B237-47C0-A615-57655965D06A

Q40148008-18D63D8D-FE26-4BA7-8F03-01D5E8D3C0A7

Q40148008-2136898E-A006-47F6-AC61-D31AFB5E3B4D

Q40148008-2FDD2C86-0737-42BD-A667-D051CD6F50A6

Q40148008-34AD3030-B32E-4C65-838E-836C79FA796B

Q40148008-4581F4EF-0BD9-40BB-BDFB-5C7F87E439B4

Q40148008-47652F32-5264-45F2-B2B3-516D3B932A00

Q40148008-4D22F148-DBB8-499A-B4FA-18538FE6FCB1

Q40148008-5C9EB01D-A67E-4E2D-832B-F682FAB11B98

P2888

Q40148008-53F12384-C757-42F6-8B85-21CCBBBDC335

P304

Q40148008-23FDE6B8-4CD3-41C0-BEE2-1874938A5923

P31

Q40148008-73641199-174E-429E-BB68-58F7F67C2A0E

P356

Q40148008-3F447148-F8FC-4C6F-A244-EAB46018C048

P433

Q40148008-FA0C2048-E137-447A-A0FB-75A2CAC4DACF

P478

Q40148008-9503A5AD-3EB1-4910-855E-A77428A42D32

P50

Q40148008-0FEFDD8B-26E2-4675-A048-EC8E76D14A2B

Q40148008-240CAF5A-E1BD-4804-9560-2350DA0D2F00

Q40148008-2828D2C1-18FE-4DE0-9241-ED364E5F7FEC

Q40148008-E8C22A5C-12F4-4995-9308-7820B10865AA

P577

Q40148008-E1BFF2B5-AD35-4AAE-AF0D-BFB42C0B47BA

P5875

Q40148008-1820ECDB-4A5D-40F9-99D1-439F67648994

P6179

Q40148008-3469B8CC-DBC4-4CB1-8060-0558A98F1812

P698

Q40148008-D3E8A7FF-A045-471E-B359-B3977428892B

P932

Q40148008-EB5CB62D-4C76-47E7-BA37-EB1C4A26EE74

P356

S00262-015-1782-5

P1433

Cancer Immunology, Immunotherapy

P1476

Toward harmonized phenotyping ...... results from an interim study.

@en

P2093

Cedrik M Britten

http://www.w3.org/2001/XMLSchema#string

Cécile Gouttefangeas

http://www.w3.org/2001/XMLSchema#string

Dominik Maurer

http://www.w3.org/2001/XMLSchema#string

Marij J P Welters

http://www.w3.org/2001/XMLSchema#string

Sjoerd H van der Burg

http://www.w3.org/2001/XMLSchema#string

Steffen Walter

http://www.w3.org/2001/XMLSchema#string

Vincenzo Bronte

http://www.w3.org/2001/XMLSchema#string

P2860

Coordinated regulation of myeloid cells by tumours

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters.

Data analysis in flow cytometry: the future just started.

Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes.

Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8(+) T cells with detection by ELISPOT and HLA-multimer staining

Immature myeloid cells and cancer-associated immune suppression.

All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.

Complexity and challenges in defining myeloid-derived suppressor cells

A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI)

P2888

s00262-015-1782-5

P304

161-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-015-1782-5

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

Christian H. Ottensmeier

Susanna Mandruzzato

P577

2016-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289366791

http://www.w3.org/2001/XMLSchema#string

P6179

1016962261

http://www.w3.org/2001/XMLSchema#string

P698

26728481

http://www.w3.org/2001/XMLSchema#string

P932

4726716

http://www.w3.org/2001/XMLSchema#string